| N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension. | N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension.
Kang K, Xiang J, Zhang X, Xie Y, Zhou M, Zeng L, Zhuang J, Kuang J, Lin Y, Hu B, Xiong Q, Yin Q, Su Q, Liao X, Wang J, Niu Y, Liu C, Tian J, Gou D., Free PMC Article | 07/12/2024 |
| KLF2 enhancer variant rs4808485 increases lupus risk by modulating inflammasome machinery and cellular homoeostasis. | KLF2 enhancer variant rs4808485 increases lupus risk by modulating inflammasome machinery and cellular homoeostasis.
Singh MK, Rallabandi HR, Zhou XJ, Qi YY, Zhao ZZ, Gan T, Zhang H, Looger LL, Nath SK., | 06/25/2024 |
| HEG1 Protects Against Atherosclerosis by Regulating Stable Flow-Induced KLF2/4 Expression in Endothelial Cells. | HEG1 Protects Against Atherosclerosis by Regulating Stable Flow-Induced KLF2/4 Expression in Endothelial Cells.
Tamargo IA, Baek KI, Xu C, Kang DW, Kim Y, Andueza A, Williams D, Demos C, Villa-Roel N, Kumar S, Park C, Choi R, Johnson J, Chang S, Kim P, Tan S, Jeong K, Tsuji S, Jo H., | 04/16/2024 |
| KLF2 Regulates Neural Differentiation of Dental Pulp-derived Stem Cells by Modulating Autophagy and Mitophagy. | KLF2 Regulates Neural Differentiation of Dental Pulp-derived Stem Cells by Modulating Autophagy and Mitophagy.
Prateeksha P, Naidu P, Das M, Barthels D, Das H. | 12/1/2023 |
| KLF2 regulates stemness of human mesenchymal stem cells by targeting FGFR3. | KLF2 regulates stemness of human mesenchymal stem cells by targeting FGFR3.
Gong Z, Shu Z, Zhou Y, Chen Y, Zhu H. | 09/29/2023 |
| KLF2 transcription suppresses endometrial cancer cell proliferation, invasion, and migration through the inhibition of NPM1. | KLF2 transcription suppresses endometrial cancer cell proliferation, invasion, and migration through the inhibition of NPM1.
Cheng X, Shen C, Liao Z. | 08/30/2023 |
| Mechanism of tumor-derived extracellular vesicles in prostatic cancer progression through the circFMN2/KLF2/RNF128 axis. | Mechanism of tumor-derived extracellular vesicles in prostatic cancer progression through the circFMN2/KLF2/RNF128 axis.
Huang S, Zhao J, Yu H, Chen G. | 08/19/2023 |
| Kruppel-like factor 2: a central regulator of B cell differentiation and plasma cell homing. | Krüppel-like factor 2: a central regulator of B cell differentiation and plasma cell homing.
Wittner J, Schuh W., Free PMC Article | 06/3/2023 |
| Circ_0043256 upregulates KLF2 expression by absorbing miR-1206 to suppress the tumorigenesis of lung cancer. | Circ_0043256 upregulates KLF2 expression by absorbing miR-1206 to suppress the tumorigenesis of lung cancer.
Zhou Y, Liu H, Wang R, Zhang M., Free PMC Article | 03/28/2023 |
| Differentiated serum levels of Kruppel-like factors 2 and 4, sP-selectin, and sE-selectin in patients with gestational diabetes mellitus. | Differentiated serum levels of Krüppel-like factors 2 and 4, sP-selectin, and sE-selectin in patients with gestational diabetes mellitus.
Zhang H, Chen Z, Wang X. | 03/7/2023 |
| Downregulated KLF2 in polycythemia vera and essential thrombocythemia induces prothrombotic gene expression. | Downregulated KLF2 in polycythemia vera and essential thrombocythemia induces prothrombotic gene expression.
Song J, Kim SJ, Gollamudi J, Thiagarajan P, Prchal JT., Free PMC Article | 03/6/2023 |
| Down-regulation of KLF2 in lung fibroblasts is linked with COVID-19 immunofibrosis and restored by combined inhibition of NETs, JAK-1/2 and IL-6 signaling. | Down-regulation of KLF2 in lung fibroblasts is linked with COVID-19 immunofibrosis and restored by combined inhibition of NETs, JAK-1/2 and IL-6 signaling.
Chrysanthopoulou A, Antoniadou C, Natsi AM, Gavriilidis E, Papadopoulos V, Xingi E, Didaskalou S, Mikroulis D, Tsironidou V, Kambas K, Koffa M, Skendros P, Ritis K., Free PMC Article | 02/22/2023 |
| Dysregulation of Kruppel-like Factor 2 and Myocyte Enhancer Factor 2D Drive Cardiac Microvascular Inflammation and Dysfunction in Diabetes. | Dysregulation of Krüppel-like Factor 2 and Myocyte Enhancer Factor 2D Drive Cardiac Microvascular Inflammation and Dysfunction in Diabetes.
Samak M, Kues A, Kaltenborn D, Klösener L, Mietsch M, Germena G, Hinkel R., Free PMC Article | 02/16/2023 |
| Heterozygous premature termination in zinc-finger domain of Kruppel-like factor 2 gene associates with dysregulated immunity. | Heterozygous premature termination in zinc-finger domain of Krüppel-like factor 2 gene associates with dysregulated immunity.
Pernaa N, Keskitalo S, Chowdhury I, Nissinen A, Glumoff V, Keski-Filppula R, Junttila J, Eklund KK, Santaniemi W, Siitonen S, Seppänen MR, Vähäsalo P, Varjosalo M, Åström P, Hautala T., Free PMC Article | 12/10/2022 |
| miR-92a-3p promotes breast cancer proliferation by regulating the KLF2/BIRC5 axis. | miR-92a-3p promotes breast cancer proliferation by regulating the KLF2/BIRC5 axis.
Yu ZH, Chen ZH, Zhou GL, Zhou XJ, Ma HY, Yu Y, Wang X, Cao XC., Free PMC Article | 11/5/2022 |
| Kruppel-like Factor 2 Inhibits Proliferation in Renal Angiomyolipoma via IL-6/JAK/STAT3 Signaling Pathway. | Kruppel-like Factor 2 Inhibits Proliferation in Renal Angiomyolipoma via IL-6/JAK/STAT3 Signaling Pathway.
Liu CY, Chang TH, Hsieh CH, Chang YH, Pang JS, Chuang CK. | 10/15/2022 |
| Relation among EGFL7, ITGB3, and KLF2 and their clinical implication in multiple myeloma patients: a prospective study. | Relation among EGFL7, ITGB3, and KLF2 and their clinical implication in multiple myeloma patients: a prospective study.
Li Y, Zhang L, Gong J., Free PMC Article | 10/1/2022 |
| Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription. | Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription.
Min J, Ma J, Wang Q, Yu D., Free PMC Article | 10/1/2022 |
| KLF2-induced circZKSCAN1 potentiates the tumorigenic properties of clear cell renal cell carcinoma by targeting the miR-1294/PIM1 axis. | KLF2-induced circZKSCAN1 potentiates the tumorigenic properties of clear cell renal cell carcinoma by targeting the miR-1294/PIM1 axis.
Li M, Zhang M, Chen M, Xiao J, Mu X, Peng J, Fan J., Free PMC Article | 07/16/2022 |
| MiR-572 promotes the development of non-small cell lung cancer by targeting KLF2. | MiR-572 promotes the development of non-small cell lung cancer by targeting KLF2.
Sun B, Zhao J, Shao ZY. | 05/28/2022 |
| KLF2 mediates the suppressive effect of BDNF on diabetic intimal calcification by inhibiting HK1 induced endothelial-to-mesenchymal transition. | KLF2 mediates the suppressive effect of BDNF on diabetic intimal calcification by inhibiting HK1 induced endothelial-to-mesenchymal transition.
Wang FF, Zhang JL, Ji Y, Yan XJ, Sun L, Zhu Y, Jin H. | 05/7/2022 |
| Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP/KLF2 in non-small cell lung cancer. | Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP/KLF2 in non-small cell lung cancer.
Ma Z, Wei K, Yang F, Guo Z, Pan C, He Y, Wang J, Li Z, Chen L, Chen Y, Xia Y., Free PMC Article | 01/29/2022 |
| KLF2 Mediates the Suppressive Effect of Laminar Flow on Vascular Calcification by Inhibiting Endothelial BMP/SMAD1/5 Signaling. | KLF2 Mediates the Suppressive Effect of Laminar Flow on Vascular Calcification by Inhibiting Endothelial BMP/SMAD1/5 Signaling.
Huang J, Pu Y, Zhang H, Xie L, He L, Zhang CL, Cheng CK, Huo Y, Wan S, Chen S, Huang Y, Lau CW, Wang L, Xia Y, Huang Y, Luo JY. | 01/15/2022 |
| KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma. | KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma.
Lu Y, Qin H, Jiang B, Lu W, Hao J, Cao W, Du L, Chen W, Zhao X, Guo H. | 01/8/2022 |
| Cilostazol Induces eNOS and TM Expression via Activation with Sirtuin 1/Kruppel-like Factor 2 Pathway in Endothelial Cells. | Cilostazol Induces eNOS and TM Expression via Activation with Sirtuin 1/Krüppel-like Factor 2 Pathway in Endothelial Cells.
Wu CH, Chiu YL, Hsieh CY, Tsung GS, Wu LS, Cheng CC, Tsai TN., Free PMC Article | 11/6/2021 |